Loading
Overweight , Obesity / Probiotic supplementation / Healthy · Interventional Study
ClinicalTrials.gov · August 12, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned 16-week randomised, placebo-controlled trial investigating whether probiotic supplementation increases satiety and alters gut microbiota in adults with overweight or obesity. No results have been reported in this registry record, and the trial is currently recruiting; the evidence base cannot be assessed until outcomes are published.
Interventional, Randomized, Parallel, Quadruple masking, Prevention purpose. Healthy, Overweight (BMI > 25), Overweight , Obesity, Male, Female, Adults, Satiety and Food Intake, Gut Microbiota Modulation; age from 20 Years; to 70 Years; accepts healthy volunteers. Intervention: Probiotic supplement. Compared with: Placebo — Placebo Comparator. n = 98. 1 site: Netherlands.
This is a planned 16-week randomised, placebo-controlled trial investigating whether probiotic supplementation increases satiety and alters gut microbiota in adults with overweight or obesity. No results have been reported in this registry record, and the trial is currently recruiting; the evidence base cannot be assessed until outcomes are published.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a clinical trial registry record describing a planned interventional study with no results reported; the trial is still recruiting and represents early-phase investigation of probiotics on appetite regulation.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07715955). This is a study registration, not published results. Lead sponsor: Maastricht University Medical Center. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 98 participants (ESTIMATED). Conditions: Healthy, Overweight (BMI > 25), Overweight , Obesity, Male, Female, Adults, Satiety and Food Intake, Gut Microbiota Modulation. Interventions: DIETARY_SUPPLEMENT: Probiotic supplementation; OTHER: Placebo. Primary outcome measures: Ad libitum food intake , From enrolment to the end of the 16-week intervention. Brief summary: The goal of this 16-week randomised, placebo-controlled parallel study is to investigate the effect of a newly formed probiotic supplement on satiety and gut microbiota composition in healthy men and women with overweight or obesity form 20-70 years old. The main question it aims to answer is: Does the probiotic supplement increase feelings of satiety and alter gut microbiota composition? Participants will: * Receive a daily dose of 6 g probiotic supplement (packed in sachets of 3 g) or placebo for 16 weeks. * Visit the research unit 3 times at baseline, week 8 and week 16 of the intervention for blood draws and delivering fecal samples. * Keep a study diary to report deviations from their daily habits and fill in food questionnaires.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.